![Octasa 400 mg Modified Release Tablets (Active substance: mesalazine) used to treat mild to moderate attacks of ulcerative colitis Stock Photo - Alamy Octasa 400 mg Modified Release Tablets (Active substance: mesalazine) used to treat mild to moderate attacks of ulcerative colitis Stock Photo - Alamy](https://c8.alamy.com/comp/WPHK7W/octasa-400-mg-modified-release-tablets-active-substance-mesalazine-used-to-treat-mild-to-moderate-attacks-of-ulcerative-colitis-WPHK7W.jpg)
Octasa 400 mg Modified Release Tablets (Active substance: mesalazine) used to treat mild to moderate attacks of ulcerative colitis Stock Photo - Alamy
![Advances in mechanistic understanding of release rate control mechanisms of extended-release hydrophilic matrix tablets | Therapeutic Delivery Advances in mechanistic understanding of release rate control mechanisms of extended-release hydrophilic matrix tablets | Therapeutic Delivery](https://www.future-science.com/cms/10.4155/tde-2016-0026/asset/images/medium/figure1.gif)
Advances in mechanistic understanding of release rate control mechanisms of extended-release hydrophilic matrix tablets | Therapeutic Delivery
![WATSONS, Trimetazidine (as Dihydrochloride) 35mg 1 Modified-Release Tablet [PRESCRIPTION REQUIRED] | Watsons Philippines WATSONS, Trimetazidine (as Dihydrochloride) 35mg 1 Modified-Release Tablet [PRESCRIPTION REQUIRED] | Watsons Philippines](https://api.watsons.com.ph/medias/prd-front-50002295.jpg?context=bWFzdGVyfGltYWdlc3wzMDcwMzF8aW1hZ2UvanBlZ3xoYjQvaGQ5Lzk0OTM2MzQ2Nzg4MTQvV1RDUEgtNTAwMDIyOTUtZnJvbnQuanBnfDdjY2RlOTllNDJjZjgwMzVkZTUxZDc3ZmY4M2E3YTA5NjhhNDc3OWY1ZjkyM2ExM2YxY2E4OWMwMzRmZmY2MTI)
WATSONS, Trimetazidine (as Dihydrochloride) 35mg 1 Modified-Release Tablet [PRESCRIPTION REQUIRED] | Watsons Philippines
![Trimzed Allopathic Trimetazidine Dihydrochloride Modified Release Tablets 60mg at Rs 200/strip in New Delhi Trimzed Allopathic Trimetazidine Dihydrochloride Modified Release Tablets 60mg at Rs 200/strip in New Delhi](https://5.imimg.com/data5/SELLER/Default/2022/2/FO/RK/HI/13166357/trimetazidine-dihydrochloride-modified-release-tablets-60mg-500x500.jpg)
Trimzed Allopathic Trimetazidine Dihydrochloride Modified Release Tablets 60mg at Rs 200/strip in New Delhi
![Trimetazidine Hydrochlorides Modified Release Tablets 35mg (Taj Pharma) - Taj Generics Pharmaceuticals | Taj Pharma Trimetazidine Hydrochlorides Modified Release Tablets 35mg (Taj Pharma) - Taj Generics Pharmaceuticals | Taj Pharma](https://tajgenerics.com/wp-content/uploads/Trimetazidine-Hydrochloride-Modified-Release-Tablets-35-mg-Taj-Pharma.jpg)
Trimetazidine Hydrochlorides Modified Release Tablets 35mg (Taj Pharma) - Taj Generics Pharmaceuticals | Taj Pharma
![Table 4 from Oral Sustained Release Tablets: An Overview with a special emphasis on Matrix Tablet | Semantic Scholar Table 4 from Oral Sustained Release Tablets: An Overview with a special emphasis on Matrix Tablet | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/705c88d54534a0b7dc824f5633ab5030ae45a1bb/9-Table4-1.png)
Table 4 from Oral Sustained Release Tablets: An Overview with a special emphasis on Matrix Tablet | Semantic Scholar
![Modified and sustained release technologies: Sustained release tablets (Matrix, Gastric retentive formulation) | SPERA PHARMA, Inc. Modified and sustained release technologies: Sustained release tablets (Matrix, Gastric retentive formulation) | SPERA PHARMA, Inc.](https://www.spera-pharma.co.jp/wp-content/uploads/2019/02/formulation03en.jpg)
Modified and sustained release technologies: Sustained release tablets (Matrix, Gastric retentive formulation) | SPERA PHARMA, Inc.
![Doxofylline Modified Release Tablets at Rs 1250/box | Pharmaceutical Tablet in Hapur | ID: 23871204291 Doxofylline Modified Release Tablets at Rs 1250/box | Pharmaceutical Tablet in Hapur | ID: 23871204291](https://5.imimg.com/data5/SELLER/Default/2021/9/VY/XA/WI/5411298/doxofylline-modified-release-tablet-500x500.jpg)
Doxofylline Modified Release Tablets at Rs 1250/box | Pharmaceutical Tablet in Hapur | ID: 23871204291
![Design and evaluation of an extended-release matrix tablet formulation; the combination of hypromellose acetate succinate and hydroxypropylcellulose - ScienceDirect Design and evaluation of an extended-release matrix tablet formulation; the combination of hypromellose acetate succinate and hydroxypropylcellulose - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1818087616302094-ajps418-fig-0007.jpg)